[Genetic and molecular biological aspects of the bladder exstrophy-epispadias complex (BEEC)].
The bladder exstrophy and epispadias complex (BEEC) is an anterior midline defect with variable expression involving the infraumbilical abdominal wall including the pelvis, urinary tract, and external genitalia. The incidence varies with regard to ethnical background, sex, and phenotypic expression, and an incidence of 1:20,000 to 1:80,000 has been observed in the middle European population. No gene defect has been attributed to BEEC thus far and chromosomal aberrations or genetic syndromes associated with BEEC have only rarely been reported. According to epidemiological data, a complex genetic as well as a multifactorial mode of inheritance could underlie BEEC. However, no single teratogenic agent or environmental factor has been identified, which could play a dominant role in the expression of the BEEC.A risk of recurrence of 0.5-3% has been described in families with one affected subject. These values correspond to an increased recurrence risk estimated to be as high as 200- to 800-fold when compared to the common population. Due to the paucity of affected sib pairs and suitable multiplex families, conventional linkage analysis to identify candidate genes causally related with BEEC appears to be unfeasible. Large association studies and consecutive linkage disequilibrium mapping should therefore lead to the identification of candidate genes. Also new methods including matrix-based comparative genomic hybridization (CGH) are promising and have successfully been used in the past (e.g., CHARGE association). Moreover, the low incidence of the BEEC requires close cooperation between clinicians in the operative and nonoperative specialties as well as geneticists for successful gene search.
Ludwig
M
M
Institut für Klinische Biochemie, Universitätsklinikum, Bonn. mludwig@uni-bonn.de
Utsch
B
B
Reutter
H
H
D001746:Bladder Exstrophy / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics* / Q000628:therapy; D004842:Epispadias / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics* / Q000628:therapy; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005820:Genetic Testing / Q000379:methods; D006801:Humans; D015994:Incidence; D008967:Molecular Biology / Q000379:methods; D015995:Prevalence; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors